Billions bet that bugs were the future of protein — then the math caught up

Food & Farming 4 min 23 sources

The 'future of food' is colliding with the slow, thin-margin reality of actually making food. Insect and lab-grown protein firms are cutting staff and going bankrupt, not because the science failed but because the money was the wrong shape. Plus: an uneven planting season, war reaching the fertilizer, and a quiet fight over how a pig is allowed to live.

Key takeaways

Insect- and lab-grown-protein startups are cutting jobs and going bankrupt — not because the science failed, but because the money was the wrong shape: buyers want protein meal under $2/kg while producers need about $4 to break even, and venture capital needs fast returns a slow physical business can't deliver.
The ordinary food system had an ordinary hard week: US corn emergence is fine nationally (76%) but lagging in 8 states, Kansas wheat is drought-hit, and the Iran war is pushing farmers to improvise fertilizer and squeezing the pistachio supply.
A quieter fight: a farm-bill provision, the Save Our Bacon Act, would stop states like California from setting their own animal-welfare rules — a battle over who decides the conditions your food is raised in.

The future of food meets the cost of making food

For a decade, investors poured money into a tidy idea: farm insects, grind them into protein meal, feed it to fish and livestock, and replace some of the strain that animal feed puts on the planet. This week that idea kept running into a wall.

Innovafeed, a French firm that raises black soldier fly larvae, announced a €51 million ($59 million) funding round — and, in the same breath, that it’s cutting about 60 jobs, most of them in research, to consolidate around its commercial plant in Nesle, France [3]. It’s not alone. The founder of a rival, FlyBox, says the whole insect-farming sector is in a “painful correction.” Several once-promising firms — Ÿnsect, Enorm, Aspire — have collapsed into bankruptcy or liquidation [5]. Lab-grown meat is feeling it too: cultivated-meat firm Aleph Farms cut jobs this week as well [8].

The science mostly works. What didn’t work was the business shape — and that’s the more useful story.

Why protein doesn’t pay like software

Here’s the mechanism, in one founder’s numbers. Commodity protein buyers — the feed mills buying in bulk — want black soldier fly meal at under £1.50 ($2) a kilo, says FlyBox’s Larry Kotch. Most Western producers need £3 ($4) or more just to break even [5]. The companies that failed, he argues, shared one assumption: that the market would pay a premium for a greener protein. “It did not” [5].

That gap is the whole problem. Food is a commodity — a raw good traded interchangeably, where one producer’s protein is priced against everyone’s, so you can’t charge more just because yours is novel. Growing it is slow, physical, and capital-heavy: you build expensive plants and grind out thin margins. Venture capital, the money funding these firms, needs the opposite — fast, software-style growth and fat returns. “A compelling narrative drives capital in, valuations get way ahead of unit economics, and then the scaling reality hits,” Kotch says [5]. The money’s clock and the business’s clock never matched.

Watch where the survivors are heading. Fresh funding this week flowed not to moonshot protein but to the unglamorous middle: $30 million into meatpacking technology in Nebraska, and established players pivoting toward premium niches like “future of dairy” ingredients and bioactive proteins for infant formula [8][11][13]. The bet now is on businesses whose economics match how food actually moves.

Down in the dirt, an uneven planting season

Away from the venture pitches, the ordinary food system was having a more ordinary kind of hard week. The US Department of Agriculture reported that 76% of the country’s corn crop had emerged from the ground by June 1 — actually a touch ahead of the five-year average [17].

But the national figure hides a split. In 8 of the top corn states, emergence is running below 75%, with Colorado, Michigan and Pennsylvania lagging their usual pace, especially in fields planted late [17]. Emergence is just the seedlings breaking the soil — the first checkpoint of the season, watched because a slow, uneven start can shadow the autumn harvest. Further west, drought has left the Kansas wheat crop with “little profit potential” for 2026, one farm analysis found [1]. None of this is a crisis yet. It’s the quiet, weather-driven uncertainty the food system runs on every single year.

War reaches the fertilizer and the pistachios

Two reminders that conflict lands on the plate by long routes. As the Iran war disrupts supply, some farmers are improvising fertilizer from whatever they can find — cow dung, compost — because the manufactured kind has grown scarce or unaffordable [6]. Synthetic fertilizer is energy-intensive to make, so war that hits fuel and trade hits the bag of fertilizer next, and the harvest after that.

The same war is squeezing pistachios. Iran is one of the world’s two big pistachio growers, and the disruption has tightened supply just as a viral social-media trend has sent demand climbing [7]. When a crop comes from only a couple of places and one of them is in turmoil, there’s no slack in the system — the price has nowhere to go but up [7].

Who decides how a pig is allowed to live?

End with a slower fight playing out in Washington. As Congress reworks the farm bill — the sprawling, every-five-years law that funds food assistance and farm subsidies — a provision called the Save Our Bacon Act would block individual states from setting their own rules for how livestock is raised [18].

Its target is California’s Proposition 12, which requires that pork sold in the state come from farms giving animals room to move — effectively banning “gestation crates,” pens so small a mother pig can’t turn around [18]. Because California is such a huge market, its rule functions as a national floor: to sell there, producers anywhere have to meet it. At least 15 states have similar bans on cramped cages for egg-laying hens [18]. The Act would erase that state-by-state power. It’s a fight, underneath, about who gets to decide the conditions your food is grown in — the state you live in, or Congress.

02 · Lesson · why it matters

A slow thing on a fast clock doesn't speed up. It breaks.

When the timeline you fund or judge something on doesn't match the timeline it actually obeys, the mismatch doesn't make it faster — it deforms it, then it snaps.

The science worked. The money didn’t.

The strangest thing about this week’s collapse of insect-protein companies is that almost nothing was wrong with the bugs.

The black soldier fly larvae grew. The protein was real and usable. The science did what it promised. What broke was the gap between two numbers: buyers would pay about $2 a kilo, and producers needed about $4 to survive. The companies that died weren’t beaten by biology. They were beaten by a mismatch — between the patient, thin-margin business of growing food and the impatient, high-return money that financed it.

That mismatch is worth understanding on its own, because it sinks far more than insect farms.

Two clocks

Every venture runs on two clocks at once, and we usually only look at one.

The first is the money’s clock — how fast the people funding the thing need it to grow and pay back. Venture capital runs fast: it wants software-style returns, a business that doubles cheaply because copying code costs almost nothing.

The second is the thing’s own clock — the pace the work actually obeys. Growing protein is slow and physical. You build costly plants, you grind out small margins, and a kilo of your protein is priced against everyone else’s, so you can’t simply charge more for being clever. That clock ticks in years and pennies, not in exponential curves.

Insect farming was financed on the first clock and lived on the second. The two never met.

The mismatch doesn’t speed the thing up

Here’s the part people get backwards. They assume that if you pour fast money on a slow thing, it goes faster. It doesn’t. It distorts.

A founder this week described the sequence exactly: “A compelling narrative drives capital in, valuations get way ahead of unit economics, and then the scaling reality hits.” The narrative pulls in money the real economics can’t support. The company builds bigger than its margins justify, because that’s what the funding rewards. The valuation floats up on the story. And then the slow clock — the one that was always there — reasserts itself, the plant can’t sell protein above cost, and the whole structure, now far too large, falls farther than it would have. The fast money didn’t make the business fast. It made it fragile.

The same trap, off the farm

Pour the wrong clock on almost anything and it deforms the same way.

A craft funded for hypergrowth stops being craft and starts cutting corners to hit the curve. A long friendship judged by what it returned this quarter withers under a question it was never built to answer. A forest planted for next year’s timber gets cut before it’s a forest. A child measured against an adult’s timeline learns mostly that they’re behind. A research problem that needs a decade, funded in twelve-month grant cycles, becomes a series of safe, small results instead of the hard, slow thing that mattered. In each case the thing doesn’t comply with the borrowed clock. It bends until it breaks.

The error is always the same shape: importing one domain’s tempo into another domain’s body, and mistaking the tempo for a law of nature.

Match the money to the metabolism

The founder who watched his industry collapse didn’t conclude that insect farming was doomed. He concluded it couldn’t survive “as a VC-backed protein play” — and that it might thrive if financed like the slow infrastructure it actually is. That’s not surrender. It’s matching the money to the metabolism of the thing.

So before you fund a project, set a deadline, or judge whether something is “working,” ask first what clock it genuinely runs on. How long does this actually take to become itself? Then ask whether the timeline you’re about to impose respects that, or fights it.

You can choose your patience. You usually can’t choose the thing’s true pace. And when the two disagree, it is almost always the borrowed clock that’s wrong — not the living thing that refuses to keep its time.

03 · Lab · your turn

Two Clocks

Rehearse setting an investor deadline against a food business's real break-even pace, and feel why fast money can't buy a faster break-even — only matching the clocks survives.